Robin J Christopherson, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 14074 Trade Center Dr Ste 137, Fishers, IN 46038 Phone: 949-291-9345 |
Jonathan Michael Mangano, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 13578 E 131st St Ste 260, Fishers, IN 46037 Phone: 317-827-7870 |
Ms. Kristi L Hindenburg, MS Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 11950 Fishers Crossing Dr, Fishers, IN 46038 Phone: 317-595-5555 |
Patrick James Hall, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 11950 Fishers Crossing Dr, Fishers, IN 46038 Phone: 317-595-5555 Fax: 317-595-5554 |
Angela Dawn Ford, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 14074 Trade Center Dr Ste 206, Fishers, IN 46038 Phone: 317-934-0044 |
Autumn M Schulze, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 13445 All American Rd, Fishers, IN 46037 Phone: 317-710-0397 |
News Archive
pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced that Dr. Paul Ashton, CEO, will lead a discussion on New Technologies in Retinal Drug Delivery at the 5th Annual Ophthalmic Drug Development and Delivery Summit to be held September 21-22, 2009 in San Diego.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
Male fetuses of mothers that are exposed to radiation during early pregnancy may have an increased chance of developing testicular cancer, according to a study in mice at The University of Texas MD Anderson Cancer Center.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
The US Patent Office has recently published the patent application (no. US 2015/0301039), which was filed by the MIPT in May this year and is titled Biological Sensor and a Method of the Production of Biological Sensor. In Russia, this development is already protected by the patent No. 2527699 with a priority date of February 20, 2013. The key feature of the sensor is the use of a linking layer for biomolecule immobilization comprising a thin film of graphene or graphene oxide.
› Verified 2 days ago